Berobenatide
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
Pfizer · Phase 3 · Recruiting · Enrollment 756
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity + T2D | n/r | 52 | n/r | n/r |
| Arm 1: Berobenatide Once Weekly | Obesity + T2D | n/r | 52 | n/r | n/r |
| Arm 2: Berobenatide Once Weekly | Obesity + T2D | n/r | 52 | n/r | n/r |
| Arm 3: Berobenatide Once Weekly | Obesity + T2D | n/r | 52 | n/r | n/r |